(S)-2-Amino-3-(4-ethoxyphenyl)propanoic acid, 95%, 500mg

(2S,4S,5S)-1-TERT-BUTYL 2-METHYL 4-HYDROXY-5-METHYLPYRROLIDINE-1,2-DICARBOXYLATE, 90.0%, 250mg

Methyl orange (C.I. 13025), 100 g

Boc-D-2,4-dimethylphenylalanine, 98.0%, 1g

ETHYL 5-(TERT-BUTYLAMINO)THIAZOLE-4-CARBOXYLATE, 95.0%, 1g

2-Butyl-2-ethyl-1,3-propanediol>98.0%(GC)25g

Diethylenetriamine, min. 98%, for synthesis, 1L, glass packaging

4,4'-Ethylenedianiline>97.0%(GC)(T)5g

(R)-4-((3R,5R,8S,10S,12S,13R,14S,17R)-3,12-Dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,10,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid, 98%, 25mg

Ethyl Orange sodium salt, 90.0%, 1kg

(S)-4-BENZYL-2-(PYRAZIN-2-YL)-4,5-DIHYDROOXAZOLE, 95%, 1g

(4-(Benzyloxy)-2,6-dimethylphenyl)boronic acid, 95.0%, 5g

((2S,4R)-4-Fluoro-1-methylpyrrolidin-2-yl)methanol, 98%, 250mg